- Udyam number
- UDYAM-TS-09-0032587

Spansules Formulations India Private Limited
About Spansules Formulations India Private Limited
Data last updated:
Spansules Formulations India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2022PTC160441. Its GSTIN is 36ABICS0231R1ZZ (Telangana).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.54 Cr. It is led by directors including Rama Devi Guttikonda and Haswanth Rao Guttikonda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Mig – 57 Dharma Reddy Colony Hyder Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2023, the company reported a revenue of ₹166.38 Cr. For the same year it recorded a net profit of ₹6.12 Cr (net margin 3.7%) and EBITDA of ₹9.79 Cr (EBITDA margin 5.9%).
The company has about 59 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹33.01 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 1 deal on record (1 funding round), with disclosed funding of ₹9.8 Cr; the latest was in April 2022.
Spansules Formulations India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-09-0032587).
Company details
Recognitions & Rankings of Spansules Formulations India
Contact details
Spansules Formulations India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3rd Floor Mig – 57 Dharma Reddy Colony Hyder Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spansules Formulations India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Spansules Formulations India Private Limited
FY 2025 filings availableSpansules Formulations India Private Limited reported revenue of ₹166.38 Cr for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹166.38 Cr | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹9.79 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹6.12 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.9% | |
| Net Profit Margin | 3.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Spansules Formulations India Private Limited, buy the company report.
Board of directors of Spansules Formulations India Private Limited
Spansules Formulations India has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Devi Guttikonda | Director | 09 Mar 2022 | 4 Years 8 Months | Current |
| Haswanth Rao Guttikonda Also directs: Spansules Pharmatech Private Limited, Spansules Life Sciences Private Limited, Spansules Formulations Private Limited and 1 more | Director | 09 Mar 2022 | 4 Years 8 Months | Current |
| Harika Rao Guttikonda | Director | 09 Mar 2022 | 4 Years 8 Months | Current |
| Venkata Subba Rao Guttikonda | Director | 09 Mar 2022 | 4 Years 8 Months | Current |
Auditor
Spansules Formulations India Private Limited is audited by RAO & SIVA ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAO & SIVA ASSOCIATES | FY 2023 | 08643S |
Shareholding
The shareholding of Spansules Formulations India Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Spansules Formulations India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jul 2025 | 101130960 | Hdfc Bank Limited | ₹1.12 Cr | Open | |
| 12 Jan 2024 | 100862495 | Hdfc Bank Limited | ₹15 Lakh | Open | |
| 25 May 2023 | 100725614 | Axis Bank Limited | ₹2.5 Cr | Open | |
| 01 Oct 2022 | 100629886 | Hdfc Bank Limited | ₹28.44 Cr | Open | |
| 10 Jun 2022 | 100595871 | Hdfc Bank Limited | ₹80.08 Lakh | Open |
To see the full charge records of Spansules Formulations India Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Spansules Formulations India Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹9.8 Cr; the latest was in April 2022.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2022 | Funding round | ₹9.8 Cr | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Spansules Formulations India Private Limited has 1 court case on record: 1 filed by Spansules Formulations India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against Medibois Laboratories Limited | Disposed |
To see the full case history of Spansules Formulations India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spansules Formulations India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Spansules Formulations India Private Limited has a workforce of 59 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 59 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Spansules Formulations India Private Limited, buy the company report.
GST
Spansules Formulations India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABICS0231R1ZZ | Telangana | Active | 01 Apr 2022 |
To see the full GST registrations and return filing status of Spansules Formulations India Private Limited, buy the company report.
Recent activity
Spansules Formulations India Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Harika Rao Guttikonda was appointed as Director on 09 Mar 2022.
1 earlier event is in the company report.
Frequently asked questions
Spansules Formulations India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2022 (4+ years old) and is registered under CIN U24230TG2022PTC160441.
Spansules Formulations India has 4 current directors:
- Rama Devi Guttikonda - Director
- Haswanth Rao Guttikonda - Director
- Harika Rao Guttikonda - Director
- Venkata Subba Rao Guttikonda - Director
The latest financial statements of Spansules Formulations India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Spansules Formulations India is 36ABICS0231R1ZZ, registered in Telangana.
The CIN (Corporate Identification Number) of Spansules Formulations India is U24230TG2022PTC160441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spansules Formulations India has 1 court case on record: 1 filed by the company.
Spansules Formulations India was incorporated on 09 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Spansules Formulations India has 1 deal on record (1 funding round), with disclosed funding of ₹9.8 Cr; the latest was in April 2022.
Harika Rao Guttikonda was appointed as Director on 09 Mar 2022. Haswanth Rao Guttikonda was appointed as Director on 09 Mar 2022. Rama Devi Guttikonda was appointed as Director on 09 Mar 2022. Spansules Formulations India has 4 board changes on record in total.
Yes, Spansules Formulations India is registered as an MSME under Udyam registration (number: UDYAM-TS-09-0032587).

